Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema

BACKGROUND: Patients with central retinal vein occlusion (CRVO) and macular edema often are treated by intravitreal ranibizumab injection (IRI). The role of changes in macular sensitivity in the positive effects of IRI on visual functions is unclear. Therefore, we assessed the relationship between m...

Descripción completa

Detalles Bibliográficos
Autores principales: Otawa, Taro, Noma, Hidetaka, Yasuda, Kanako, Narimatsu, Akitomo, Asakage, Masaki, Tanaka, Akina, Goto, Hiroshi, Shimura, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166445/
https://www.ncbi.nlm.nih.gov/pubmed/35658906
http://dx.doi.org/10.1186/s12886-022-02478-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166445/
https://www.ncbi.nlm.nih.gov/pubmed/35658906
http://dx.doi.org/10.1186/s12886-022-02478-9

Ejemplares similares